N6‐methyladenosine‐modified circRNA RERE modulates osteoarthritis by regulating β‐catenin ubiquitination and degradation
Cell Proliferation2022Vol. 56(1), pp. e13297–e13297
Citations Over TimeTop 10% of 2022 papers
Abstract
Our study is a proof-of-concept demonstration for targeting m6A-modified circRERE and its target miR-195-5p/IRF2BPL/β-catenin as potential therapeutic strategies for OA treatment.
Related Papers
- → Enzyme-Instructed Assembly and Disassembly Processes for Targeting Downregulation in Cancer Cells(2017)146 cited
- → Downregulation of miR-140-3p is a Cause of Upregulation of Rhoa Protein in Bronchial Smooth Muscle of Murine Experimental Asthma(2021)7 cited
- → Downregulation of p21/WAF1 Expression by Thymidylate Synthase(2001)17 cited
- → Viral Infection and Abnormal Brain Development: A DNA Microarray Study(2007)1 cited
- → Comparative Transcriptomics of PKD1 Downregulation and PKA Upregulation or Downregulation(2022)